Supporting Statement B

Status: Original and derived artifacts are available for this document.

Download: docx | pdf | html

National HIV Prevention Program Monitoring and Evaluation Data 

OMB No. 0920-0696


REVISION


Supporting Statement B





April 27, 2026











Contact Information

Kimberly Evans, PhD
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of HIV Prevention
Translation and Evaluation Branch
Centers for Disease Control and Prevention
1600 Clifton Rd NE, Mailstop H24-5
Atlanta, GA 30329
Voice: (404)639-1440
Fax:(404-639-0929)
Email: [email protected]


TABLE OF CONTENTS

B. COLLECTIONS OF INFORMATION EMPLOYING STATISTICAL METHODS
1. Respondent Universe and Sampling Methods
2. Procedures for the Collection of Information
3. Methods to Maximize Response Rates and Deal with Nonresponse
4. Tests of Procedures or Methods to be Undertaken
5. Individuals Consulted on Statistical Aspects and Individuals Collecting and/or Analyzing Data





























B. Statistical Methods
This collection does not employ statistical methods.  

1.	Respondent Universe and Sampling 
The respondents are all agencies and organizations funded by the Centers for Disease Control and Prevention (CDC) Division of HIV Prevention (DHP) to conduct HIV prevention activities or implement services designed to reduce HIV transmission. National HIV Prevention Program Monitoring and Evaluation (NHM&E) data are collected in the process of delivering the CDC-funded prevention services.  Data will be collected from each recipient for every client receiving HIV prevention services funded by CDC, either directly funded from CDC or indirectly funded through CDC-funded health department jurisdictions.  This includes approximately 59 directly funded state and city health departments (HDs), and approximately 112 directly-funded community-based organizations (CBOs). All recipients report all funded HIV prevention service data; no sampling or respondent selection will be used. 

2. Procedures for the Collection of Information
Not applicable. Though data elements in this ICR are standardized, data collection across funded HDs and CBOs is not standardized. Data are collected as part of the usual and customary practices of the recipients during their daily health service operations. Recipients use their own data collection instruments and processes. All funded HDs and CBOs under CDC HIV prevention program co-operative agreements submit NHM&E data to CDC through an approved CDC data system. CDC is currently using EvaluationWeb® and REDCap for NHM&E data submission. NHM&E data is key-entered into EvaluationWeb® or the recipients’ own software system and then uploaded to EvaluationWeb®.  Data in EvaluationWeb® is checked for data quality and conformity to NHM&E requirements, placed in analyzable data sets, and transmitted to CDC in encrypted form via Transport Layer Security (TLS) 1.2 as required by CDC. No personally identifying information is submitted to CDC. REDCap is used for submission of aggregate level and qualitative data only. In 2027, data submission will transition to One CDC Data Platform (1-CDP). NHM&E data are submitted to CDC twice yearly.

3.  Methods to Maximize Response Rates and Deal with Nonresponse
Not applicable. Respondents are required to provide this information to CDC on a semiannual basis as a condition of the co-operative agreement.

4.  Tests of Procedures or Methods to be Undertaken
Not applicable. There was no additional testing taken as this is a currently approved OMB collection. 

5.  Individuals Consulted on Statistical Aspects and Individuals Collecting and/or Analyzing Data.
The NHM&E data variables and values have been developed over the past twenty years by multiple branches and contractors, as coordinated by the former Program Evaluation Branch (now the Translation and Evaluation Branch) under the direction of the Division of HIV Prevention; National Center for HIV, Viral Hepatitis, STD, and TB Prevention. Data will be analyzed by the Translation and Evaluation Branch staff.